Orthopediatrics (KIDS) Net Income towards Common Stockholders (2016 - 2026)
Orthopediatrics' quarterly Net Income towards Common Stockholders came in at -$10.7 million in Q1 2026, little changed year-on-year from -$10.7 million in Q1 2025, and down 5.78% quarter-over-quarter from -$10.1 million in Q4 2025.
Orthopediatrics has reported Net Income towards Common Stockholders for 11 years, with the latest figure at -$10.7 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders changed 0.26% year-over-year to -$10.7 million; the trailing twelve-month figure through Mar 2026 stood at -$39.7 million (up 2.46% YoY), and the FY2025 full-year result was -$39.6 million, down 4.83% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$10.7 million, down from -$10.1 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $18.5 million in Q3 2022, with the low at -$16.1 million in Q4 2024.
- Average Net Income towards Common Stockholders over 5 years is -$6.3 million, with a median of -$7.8 million recorded in 2024.
- Peak annual rise in Net Income towards Common Stockholders reached 943.83% in 2022, while the deepest fall reached 11000.0% in 2022.
- Tracing KIDS's Net Income towards Common Stockholders over 5 years: stood at -$7.8 million in 2022, then advanced by 14.74% to -$6.7 million in 2023, then slumped by 140.16% to -$16.1 million in 2024, then surged by 37.13% to -$10.1 million in 2025, then dropped by 5.78% to -$10.7 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$10.7 million (Q1 2026), -$10.1 million (Q4 2025), and -$11.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | -10.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.69 Mn |
| Dec 31, 2025 | -10.10 Mn |
| Sep 30, 2025 | -11.77 Mn |
| Jun 30, 2025 | -7.11 Mn |
| Mar 31, 2025 | -10.66 Mn |
| Dec 31, 2024 | -16.07 Mn |
| Sep 30, 2024 | -7.92 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Mar 31, 2024 | -7.81 Mn |
| Dec 31, 2023 | -6.69 Mn |
| Sep 30, 2023 | -4.59 Mn |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | -6.81 Mn |
| Dec 31, 2022 | -7.85 Mn |
| Sep 30, 2022 | 18.54 Mn |
| Jun 30, 2022 | -333,000.00 |
| Mar 31, 2022 | -9.10 Mn |
| Dec 31, 2021 | 72,000.00 |
| Sep 30, 2021 | -2.20 Mn |
| Jun 30, 2021 | -3.76 Mn |
| Mar 31, 2021 | -10.38 Mn |
| Dec 31, 2020 | -14.01 Mn |
| Sep 30, 2020 | -4.54 Mn |
| Jun 30, 2020 | -9.45 Mn |
| Mar 31, 2020 | -4.95 Mn |
| Dec 31, 2019 | -5.43 Mn |
| Sep 30, 2019 | -2.66 Mn |
| Jun 30, 2019 | -2.62 Mn |
| Mar 31, 2019 | -3.02 Mn |
| Dec 31, 2018 | -2.47 Mn |
| Sep 30, 2018 | -1.87 Mn |
| Jun 30, 2018 | -2.69 Mn |
| Mar 31, 2018 | -5.00 Mn |
| Dec 31, 2017 | -15.08 Mn |
| Sep 30, 2017 | -3.02 Mn |
| Jun 30, 2017 | -2.72 Mn |
| Mar 31, 2017 | -2.71 Mn |
| Dec 31, 2016 | -5.29 Mn |
| Sep 30, 2016 | -2.41 Mn |